LAWLIS V BRYAN
Insider CIK 1247681 · BMRN Director · KBIO Director · STRO Director · CHRS Director · AGLE Director · GERN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GERN GERON CORP | A Award deriv | 2025-05-21 | 2025-05-22 | 180,000 | — | $0 | 180,000 | SEC↗ |
| GERN GERON CORP | P Buy | 2025-05-09 | 2025-05-13 | 13,300 | $1.18 | $15.7K | 13,300 | SEC↗ |
| GERN GERON CORP | M Exercise deriv | 2024-05-15 | 2024-05-17 | 35,000 | — | $0 | 0 | SEC↗ |
| GERN GERON CORP | M Exercise | 2024-05-15 | 2024-05-17 | 35,000 | $1.94 | $67.9K | 35,000 | SEC↗ |
| GERN GERON CORP | S Sale | 2024-05-15 | 2024-05-17 | 35,000 | $3.75 | $131.3K | 0 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2024-05-09 | 2024-05-10 | 180,000 | — | $0 | 180,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2023-05-31 | 2023-06-02 | 125,000 | — | $0 | 125,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-05-23 | 2023-05-24 | 4,190 | — | $0 | 33,140 | SEC↗ |
| GERN GERON CORP | M Exercise deriv | 2023-05-11 | 2023-05-11 | 35,000 | — | $0 | 0 | SEC↗ |
| GERN GERON CORP | M Exercise | 2023-05-11 | 2023-05-11 | 35,000 | $1.10 | $38.5K | 35,000 | SEC↗ |
| GERN GERON CORP | S Sale | 2023-05-11 | 2023-05-11 | 35,000 | $3.00 | $105.0K | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-04-03 | 2023-04-04 | 8,500 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-04-03 | 2023-04-04 | 8,500 | $97.09 | $825.3K | 28,950 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2023-04-03 | 2023-04-04 | 8,500 | $67.81 | $576.4K | 37,450 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2022-06-07 | 2022-06-09 | 43,000 | — | $0 | 43,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-05-24 | 2022-05-26 | 4,980 | — | $0 | 28,950 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2022-05-10 | 2022-05-11 | 125,000 | — | $0 | 125,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-04-14 | 2022-04-18 | 4,250 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-04-14 | 2022-04-18 | 4,250 | $37.46 | $159.2K | 28,220 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-04-14 | 2022-04-18 | 4,250 | $83.66 | $355.6K | 23,970 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-01-14 | 2022-01-19 | 4,250 | — | $0 | 4,250 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-01-14 | 2022-01-19 | 4,250 | $37.46 | $159.2K | 28,220 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-01-14 | 2022-01-19 | 4,250 | $87.61 | $372.3K | 23,970 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2021-06-08 | 2021-06-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2021-05-25 | 2021-05-27 | 5,120 | — | $0 | 23,970 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2021-05-11 | 2021-05-13 | 83,000 | — | $0 | 83,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-04-15 | 2021-04-19 | 7,500 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-04-15 | 2021-04-19 | 7,500 | $76.90 | $576.8K | 18,850 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-04-15 | 2021-04-19 | 7,500 | $26.49 | $198.7K | 26,350 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-02-16 | 2021-02-18 | 7,500 | — | $0 | 7,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-02-16 | 2021-02-18 | 7,500 | $26.49 | $198.7K | 26,350 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-02-16 | 2021-02-18 | 7,500 | $87.41 | $655.6K | 18,850 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2021-01-11 | 2021-01-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2020-06-08 | 2020-06-10 | 28,100 | — | $0 | 28,100 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2020-06-05 | 2020-06-09 | 83,000 | — | $0 | 83,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-06-05 | 2020-06-09 | 4,430 | $107.46 | $476.0K | 18,850 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-05-27 | 2020-05-29 | 4,300 | — | $0 | 23,280 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2020-03-17 | 2020-03-18 | 3,750 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2020-03-17 | 2020-03-18 | 3,750 | $21.51 | $80.7K | 22,730 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-03-17 | 2020-03-18 | 3,750 | $75.39 | $282.7K | 18,980 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-03-16 | 2020-03-18 | 4,610 | $76.52 | $352.8K | 18,980 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2020-01-10 | 2020-01-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2019-12-17 | 2019-12-19 | 3,750 | — | $0 | 3,750 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2019-12-17 | 2019-12-19 | 3,750 | $21.51 | $80.7K | 27,340 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2019-12-17 | 2019-12-19 | 3,750 | $83.36 | $312.6K | 23,590 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2019-09-17 | 2019-09-18 | 3,750 | — | $0 | 7,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2019-09-17 | 2019-09-18 | 3,750 | $74.47 | $279.3K | 23,590 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2019-09-17 | 2019-09-18 | 3,750 | $21.51 | $80.7K | 27,340 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2019-06-17 | 2019-06-19 | 3,750 | — | $0 | 11,250 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2019-06-17 | 2019-06-19 | 3,750 | $81.08 | $304.1K | 23,590 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2019-06-17 | 2019-06-19 | 3,750 | $21.51 | $80.7K | 27,340 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2019-06-07 | 2019-06-07 | 12,400 | — | $0 | 12,400 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2019-06-06 | 2019-06-07 | 70,000 | — | $0 | 70,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-06-04 | 2019-06-06 | 4,430 | — | $0 | 23,590 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2019-03-27 | 2019-03-29 | 2,150 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2019-03-27 | 2019-03-29 | 2,150 | $89.76 | $193.0K | 19,160 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2019-03-27 | 2019-03-29 | 2,150 | $14.39 | $30.9K | 21,310 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2019-01-11 | 2019-01-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2018-12-27 | 2018-12-28 | 2,150 | — | $0 | 2,150 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2018-12-27 | 2018-12-28 | 2,150 | $14.39 | $30.9K | 21,310 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-12-27 | 2018-12-28 | 2,150 | $82.53 | $177.4K | 19,160 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2018-09-27 | 2018-09-28 | 2,150 | — | $0 | 4,300 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2018-09-27 | 2018-09-28 | 2,150 | $14.39 | $30.9K | 21,310 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-09-27 | 2018-09-28 | 2,150 | $97.93 | $210.5K | 19,160 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | A Award deriv | 2018-09-26 | 2018-09-27 | 26,033 | — | $0 | 26,033 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2018-07-13 | 2018-07-17 | 36,800 | — | $0 | 36,800 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2018-06-27 | 2018-06-29 | 2,150 | — | $0 | 6,450 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2018-06-27 | 2018-06-29 | 2,150 | $14.39 | $30.9K | 21,310 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-06-27 | 2018-06-29 | 2,150 | $93.52 | $201.1K | 19,160 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-06-05 | 2018-06-07 | 4,300 | — | $0 | 19,160 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2018-05-15 | 2018-05-17 | 70,000 | — | $0 | 70,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2018-04-17 | 2018-04-19 | 3,750 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2018-04-17 | 2018-04-19 | 3,750 | $38.59 | $144.7K | 18,610 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-04-17 | 2018-04-19 | 3,750 | $85.00 | $318.8K | 14,860 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2018-01-02 | 2018-01-04 | 3,750 | — | $0 | 3,750 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-01-02 | 2018-01-04 | 3,750 | $88.84 | $333.1K | 14,860 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2018-01-02 | 2018-01-04 | 3,750 | $38.59 | $144.7K | 18,610 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-09-15 | 2017-09-19 | 3,750 | — | $0 | 7,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-09-15 | 2017-09-19 | 3,750 | $38.59 | $144.7K | 19,660 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-09-15 | 2017-09-19 | 3,750 | $91.26 | $342.2K | 15,910 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-06-16 | 2017-06-20 | 3,750 | — | $0 | 11,250 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-06-16 | 2017-06-20 | 3,750 | $38.59 | $144.7K | 19,660 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-06-16 | 2017-06-20 | 3,750 | $90.00 | $337.5K | 15,910 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2017-06-06 | 2017-06-08 | 4,910 | — | $0 | 4,910 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2017-06-06 | 2017-06-08 | 2,050 | — | $0 | 15,910 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2017-05-17 | 2017-05-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2017-05-09 | 2017-05-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-03-01 | 2017-03-02 | 7,500 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-03-01 | 2017-03-02 | 7,500 | $95.00 | $712.5K | 13,860 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-03-01 | 2017-03-02 | 7,500 | $17.33 | $130.0K | 21,360 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2016-11-09 | 2016-11-14 | 7,500 | — | $0 | 7,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2016-11-09 | 2016-11-14 | 7,500 | $17.33 | $130.0K | 21,360 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-11-09 | 2016-11-14 | 7,500 | $95.00 | $712.5K | 13,860 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2016-07-27 | 2016-07-28 | 1,100 | — | $0 | 15,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2016-07-27 | 2016-07-28 | 1,100 | $17.33 | $19.1K | 14,960 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-07-27 | 2016-07-28 | 1,100 | $95.39 | $104.9K | 13,860 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2016-07-22 | 2016-07-26 | 6,400 | — | $0 | 16,100 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-07-22 | 2016-07-26 | 6,400 | $95.01 | $608.1K | 13,860 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2016-07-22 | 2016-07-26 | 6,400 | $17.33 | $110.9K | 20,260 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-06-20 | 2016-06-21 | 550 | $82.77 | $45.5K | 13,860 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | J Other | 2016-06-06 | 2017-10-13 | 0 | — | $0 | 13,360 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2016-06-06 | 2016-06-08 | 4,440 | — | $0 | 4,440 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-06-06 | 2016-06-08 | 1,510 | — | $0 | 14,410 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2016-05-24 | 2016-05-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2016-05-17 | 2016-05-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2015-11-16 | 2015-11-18 | 7,500 | — | $0 | 22,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-11-16 | 2015-11-18 | 1,050 | $104.26 | $109.5K | 11,850 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-11-16 | 2015-11-18 | 7,500 | $17.33 | $130.0K | 19,350 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-11-16 | 2015-11-18 | 7,500 | $107.27 | $804.5K | 11,850 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2015-06-10 | 2015-06-18 | 3,300 | — | $0 | 3,300 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2015-06-10 | 2015-06-18 | 1,100 | — | $0 | 12,900 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2015-05-18 | 2015-05-19 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2015-04-01 | 2015-04-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2015-04-01 | 2015-04-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2015-04-01 | 2015-04-03 | 6,250 | — | $0 | 6,250 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2015-04-01 | 2015-05-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2015-04-01 | 2015-05-27 | 6,250 | — | $0 | 6,250 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2015-04-01 | 2015-05-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2014-12-31 | 2015-01-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2014-11-06 | 2014-11-12 | 14,997 | — | $0 | 14,997 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2014-06-18 | 2014-06-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2014-06-04 | 2014-06-06 | 6,600 | — | $0 | 6,600 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-06-04 | 2014-06-06 | 2,100 | — | $0 | 11,800 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2014-05-20 | 2014-05-21 | 35,000 | — | $0 | 35,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-05-16 | 2014-05-19 | 1,700 | $56.87 | $96.7K | 9,700 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-12-09 | 2013-12-11 | 2,900 | $69.76 | $202.3K | 11,400 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2013-08-29 | 2013-09-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2013-05-22 | 2013-05-24 | 35,000 | — | $0 | 35,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2013-05-15 | 2013-05-17 | 8,500 | — | $0 | 8,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-05-15 | 2013-05-17 | 3,400 | — | $0 | 14,300 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2012-05-17 | 2012-05-18 | 35,000 | — | $0 | 35,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-05-15 | 2013-02-11 | 6,400 | $14.39 | $92.1K | 92,100 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-05-15 | 2013-02-11 | 6,400 | $14.39 | $92.1K | 19,800 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-05-15 | 2013-02-11 | 8,900 | $38.51 | $342.7K | 10,900 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-05-15 | 2012-05-17 | 6,400 | $14.39 | $92.1K | 92,100 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-05-15 | 2012-05-17 | 6,400 | $14.39 | $92.1K | 19,800 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-05-15 | 2012-05-17 | 8,900 | $38.51 | $342.7K | 13,400 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2012-05-08 | 2012-05-10 | 8,500 | — | $0 | 98,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2012-05-08 | 2012-05-10 | 3,400 | — | $0 | 13,400 | SEC↗ |